Respiratory syncytial virus infection in infants and young children

Journal of Family Practice

Volumn 45, Issue 6, 1997, Pages 473-481

  Levy, Barcey T ^a   Graber, Mark A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Bronchiolitis; Child care; Infant care; Respiratory syncytial virus, human

Indexed keywords

ADRENALIN; ALPHA2A INTERFERON; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; BUDESONIDE; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN; IPRATROPIUM BROMIDE; OXYGEN; PLACEBO; RETINOL; RIBAVIRIN; SALBUTAMOL; SODIUM CHLORIDE; STEROID;

BRONCHIOLITIS; CHILD; CHILD HOSPITALIZATION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG MEGADOSE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LOWER RESPIRATORY TRACT INFECTION; MORTALITY; OXYGEN SATURATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VIRUS INFECTION; VIRUS TRANSMISSION; WHEEZING;

ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; HOSPITALIZATION; HUMANS; INFANT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RIBAVIRIN;

EID: 0031449309     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288:498-505.
2. Paisley JW, Lauer BA, McIntosh K, Glode MP, Schacter J, Rumack C. Pathogens associated with acute lower respiratory infection in young children. Pediatr Infect Dis 1984; 3:14-19.
3. Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr 1993; 23:50-79.
4. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140:543-6.
5. Reese RE, Betts RF. A practical approach to infectious disease. Boston, Mass: Little, Brown & Co, 1996.
6. Heilman CA. Respiratory syncytial and parainfluenza viruses. J Infect Dis 1990; 161:402-6.
7. La Via WV, Marks MI, Stutman HR. Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment and prevention. J Pediatr 1992; 121:503-10.
8. Hall CB, Hall WJ. Bronchiolitis. In: Mandel GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York, NY: Churchill Livingstone, 1995:612-19.
9. Morris JA, Blount RE, Savage RE. Recovery of cytopathic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 1956; 92:544-9.
10. Chanock RM, Finberg L. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA) I. Isolation, properties, and characterization. II. Epidemiologic aspects of infection in infants and young children. Am J Hyg 1957; 66:281-300.
11. Kingsbury DW, Bratt MA, Choppin PW, Hanson RP, Hosaka V, ter Meulen V, et al. Paramyxoviridae. Intervirology 1978; 10:137-52.
12. Lambert DM, Pons MW, Mbuy GN, et al. Nucleic acids of respiratory syncytial virus. J Virol 1980; 36:837-46.
13. Heilman CA. Respiratory syncytial and parainfluenzae viruses. J Infect Dis 1990; 161:402-6.
14. Hall CB, McCarthy CA. Respiratory syncytial virus. In: Mandel GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York, NY: Churchill Livingstone, 1995:1501-19.
15. Storch GA, Hall CB, Anderson LJ, Park CS, Dohner DE. Antigenic and nucleic acid analysis of nosocomial isolates of respiratory syncytial virus. J Infect Dis 1993; 167:562-6.
16. McConnochie KM, Hall CV, Walsh EE, Roghmann KJ. Variation in severity of respiratory syncytial virus infection with subtype. J Pediatr 1990; 117:52-62.
17. Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, Hildreth SW, Anderson LJ. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 1990; 162:1283-90.
18. Heikkinen T, Waris M, Ruuskanen O, Putto-Laurila A. Incidence of acute otitis media associated with group A and B respiratory syncytial virus infections. Acta Paediatrica 1995; 84:419-23.
19. Welliver RC, Wong DT, Sun M, Middleton E, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305:841-6.
20. Welliver RC, Sun M, Rinaldo D, Ogra PL. Predictive value of RSV-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr 1986; 109:776-80.
21. Volovitz B, Welliver RC, DeCastro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988; 24:504-7.
22. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 1969; 89:405-21.
23. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Parrott RH. Respiratory syncytial virus disease in infants despite prior administration of antigenic in activated vaccine. Am J Epidemiol 1969; 89:422-34.
24. Chanock RM, Parrott RH, Connors M, Collins PL, Murphy BR. Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization. Pediatrics 1992; 90:137-43.
25. Kim HW, Arrobio JO, Brandt CD, Jeffries BC, Pyles G, Reid JL, et al. Epidemiology of respiratory syncytial virus in Washington, DC. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 1973; 98:216-25.
26. Hall CB, Kopelman AE, Douglas RG, Geiman JM, Meagher MP. Neonatal respiratory syncytial virus infection. N Engl J Med 1979; 300:393-6.
27. Bruhn FW, Mokrohisky ST, McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr 1977; 90:382-6.
28. Maneker AJ, Petrack EM, Kung SE. Contribution of routine pulse oximetry to evaluation and management of patients with respiratory illness in a pediatric emergency department. Ann Emerg Med 1995; 25:36-40.
29. Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 1992; 145:106-9.
30. Korppi M, Leinonen M, Koskela M, Mäkelä PH, Lavniala K. Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr Infect Dis J 1989; 8:687-92.
31. Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr 1988; 113:266-71.
32. Brasfield DM, Stagno S, Whitley RJ, Cloud G, Cassell G, Tiller M. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics 1987; 79:76-83.
33. Hall CB, Douglas RG. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99:100-3.
34. Madge P, Paton JY, McColl JH, Mackie PL. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992; 340:1079-83.
35. Hall CB. The shedding and spreading of respiratory syncytial virus. Pediatr Res 1977; 11:236-9.
36. Hall CB, Douglas RG Jr, Geiman JM. Respiratory syncytial virus infections in infants; quantitation and duration of shedding. J Pediatr 1976; 89:11-15.
37. Hall CB, Geiman JM, Biggar R, Kotok DI, Hogan PM, Douglas RG Jr. Respiratory syncytial virus infection within families. N Engl J Med 1976; 294:414-19.
38. Balough K, Ahrens R. Respiratory syncytial virus. Epi-gram [newsletter published by Hospital Epidemiology, University of Iowa Hospitals and Clinics] 1990; 5:1-7.
39. Michaels MG, Serdy C, Barbadora K, Green M, Apalsch A, Wald ER. Respiratory syncytial virus: a comparison of diagnostic modalities. Pediatr Infect Dis J 1992; 11:613-16.
40. Kellogg JA. Culture vs direct antigen assays for detection of microbial pathogens from lower respiratory tract specimens suspected of containing the respiratory syncytial virus. Arch Pathol Lab Med 1991; 115:451-8.
41. Hall CB, Douglas RG Jr. Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis 1975; 131:1-5.
42. Freymuth F, Eugene G, Vabret A, et al. Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with a DNA enzyme immunoassay. J Clin Microbiol 1995; 33:3352-5.
43. Halonen P, Herholzer J, Zigler T. Advances in the diagnosis of respiratory virus infections. Clin Diagn Virol 1996; 5:91-100.
44. Newcomb R. Use of adrenergic bronchodilators by pediatric allergists and pulmonologists. Am J Dis Child 1989; 143:481-5.
45. Schuh S, Canny G, Reisman J, Kerem E, Bentur L, Petric M, Levison H. Nebulized albuterol in acute bronchiolitis. J Pediatr 1990; 117:633-7.
46. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991; 118:807-11.
47. Schweich PJ, Hurt TL, Walkley EI, Mullen N, Archibald LF. The use of nebulized albuterol in wheezing infants. Pediatr Emerg Care 1992; 8:184-8.
48. The Merck Index, 12th ed. Whitehouse Station, NJ: Merck & Co, Inc, 1996:221.
49. Reijonen T, Korppi M, Pitkakangas S, Tenhola S, Remes K The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med 1995; 149:686-92.
50. Waisman Y, Klein BL, Boenning DA, Ypuong GM, Chamberlain JM, O;Donnell R, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngo-tracheitis (croup). Pediatrics 1992; 89:302-6.
51. Ho L, Collis G, Landau LI, LeSouef PN. Effect of salbutamol on oxygen saturation in bronchiolitis. Arch Dis Child 1991; 66:1061-4.
52. Stokes GM, Milner AD, Hodges IG, Henry RL, Elphick MC. Nebulized therapy in acute severe bronchiolitis in infancy. Arch Dis Child 1983; 58:279-83.
53. Gadomski AM, Lichenstein R, Horton L, King J, Keane V, Permutt T. Efficacy of albuterol in the management of bronchiolitis. Pediatrics 1994; 93:907-12.
54. Menon K, Sutcliffe T, Massen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995; 126:1004-7.
55. Kristjansson S, Lodrup Carlsen KC, Wennergren G, Strannegard IL, Carlsen KH. Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch Dis Child 1993; 69:650-4.
56. Schuh S, Johnson D, Canny G. Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Pediatrics 1992; 90:920-3.
57. Nutman J, Brooks LJ, Deakins KM, Baldesare KK, Witte MK, Red MD. Racemic versus L-epinephrine aerosol in the treatment of postextubation laryngeal edema: results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22:1591-4.
58. Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol 1990; 9:181-5.
59. Carlsen KH, Leegaard J, Larsen S, Orstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child 1988; 63:1428-33.
60. Maayan C, Itzhaki T, Bar-Yishay E, Gross S, Tal A. The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate. Pediatr Pulmonol 1986; 2:9-14.
61. Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med 1996; 150:512-7.
62. American Academy of Pediatrics Committee on Infectious Diseases [review]. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 1993; 92:501-4.
63. American Academy of Pediatrics Committee on Infectious Diseases [review]. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 1996; 97:137-40.
64. Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med 1983; 308:1443-7.
65. Rodriguez WJ, Kim HW, Brandt CD, Fink RJ, Getson PR, Arrobio J, Murphy TM. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J 1987; 6:159-63.
66. Taber LH, Knight V, Gilbert BE, McClung HW, Wilson SZ. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 1983; 72:613-18.
67. Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit Care Med 1994; 22:566-72.
68. Janai HK, Stutman HR, Zaleska M, Rub B, Eyzaguirre M, Marks MI, Nussbaum E. Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 1993; 12:214-8.
69. Wheeler JG, Wooford J, Turner RB. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr Infect Dis J 1993; 12:209-13.
70. Sung RY, Yin J, Oppenheimer SJ, Tam JS, Lav J. Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a. Arch Dis Child 1993; 69:440-2.
71. McDowell SF, Papic Z, Bresee JS, Larranaga C, Mendez M, Sowell AL, et al. Treatment of respiratory syncytial virus infection with vitamin A - a randomized, placebo-controlled trial in Santiago, Chile. Pediatr Infect Dis J 1996; 15:782-6.
72. Bresee JS, Fischer M, Dowell SF, Johnston BD, Biggs VM, Levine RS, et al. Vitamin A therapy for children with respiratory syncytial virus infection - a multicenter trial in the United States. Pediatr Infect Dis J 1996; 15:777-82.
73. Connor E, Top F, Kramer A, Schneider M, Love J, Carlin D, et al. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997; 99:93-9.
74. Rodriquez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EAF, Meissner HC, et al. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections. Pediatrics 1997; 99:454-61.
75. Murray M, Webb MS, O'Callaghan C, Swarbrick AS, Milner AD. Respiratory status and allergy after bronchiolitis. Arch Dis Child 1992; 67:482-7.
76. Tepper RS, Rosenberg D, Eigen H, Reister T. Bronchodilator responsiveness in infants with bronchiolitis. Pediar Pulmonol 1994; 17:81-5.
77. Gurwitz D, Mindorff D, Levison H. Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J Pediatr 1981; 98:551-5.
78. Korppi M, Kuikka L, Reijonen T, Remes K. Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study. Arch Pediatr Adolesc Med 1994; 148:1079-84.